TrueBlue Analyst Price Targets - Benzinga

TrueBlue Inc

TBINYSE

Trade with Public

Trade with Public

$8.82

0.010.11%

마지막 업데이트: Oct 13, 4:00 PM

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 옵션 주식 보고서

TrueBlue Analyst Price Targets - Benzinga

TrueBlue Analyst Price Targets

Wall Street analyst price targets and consensus rating for TrueBlue (TBI).

Price Target Range — 5 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingOutperform# Analysts2Avg. Consensus PT$10Upside to Avg. PT+7.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 5, 2025	BMO Capital	Jeffrey Silber	PT Cut	Outperform	$8→$6
Aug 6, 2025	BMO Capital	Jeffrey Silber	PT Raise	Outperform	$7→$8
Nov 5, 2024	BMO Capital	Jeffrey Silber	PT Cut	Outperform	$11→$10
Aug 7, 2024	BMO Capital	Jeffrey Silber	PT Cut	Outperform	$13→$12
Jun 17, 2024	BMO Capital	Jeffrey Silber	Maintained	Outperform	$13
May 8, 2024	BMO Capital	Jeffrey Silber	PT Cut	Outperform	$15→$13
May 7, 2024	Baird	Mark Marcon	PT Cut	Outperform	$14→$13

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BMO Capital Maintains Outperform on TrueBlue, Lowers Price Target to $6

BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and lowers the price target from $8 to $6.

Benzinga Newsdesk

PRO
BMO Capital Maintains Outperform on TrueBlue, Raises Price Target to $8

BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and raises the price target from $7 to $8.

Benzinga Newsdesk

PRO
BMO Capital Maintains Outperform on TrueBlue, Lowers Price Target to $10

BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and lowers the price target from $11 to $10.

Benzinga Newsdesk

PRO
BMO Capital Maintains Outperform on TrueBlue, Lowers Price Target to $12

BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and lowers the price target from $13 to $12.

Benzinga Newsdesk

PRO
BMO Capital Maintains Outperform on TrueBlue, Maintains $13 Price Target

BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and maintains $13 price target.

Benzinga Newsdesk

PRO
BMO Capital Maintains Outperform on TrueBlue, Lowers Price Target to $13

BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and lowers the price target from $15 to $13.

Benzinga Newsdesk